US9487818: Top2A inhibition by temozolomide and its predictive value of GBM patient's survival

Acces sibility Controls

Patent No:: US9487818
Application No:: 13/825750
Filing Date:: 10-07-2013
Issue Date:: 08-11-2016
Applicant:: New Millennium Indian Technology Leadership Initiative (NMITLI)
Inventor(s):: Kumaravel Somasundaram; Arivazhagan A; Kandavel Thennarasu; Alangar Sathyaranjandas Hegde; Ashwathnarayana Rao Chandramouli; Vani Santosh; Paturu Kondaiah; Manchanahalli Rangaswamy Satyanarayana Rao
Country:: United States of America

Disclaimer: Information available on this portal is sourced from various organizations and is provided for informational purposes only. Users are advised to verify details from the respective official sources.

Acces sibility Controls

Patents

US9487818: Top2A inhibition by temozolomide and its predictive value of GBM patient's survival

विज्ञान एवं प्रौद्योगिकी विभाग

Department of
Science and Technology

Acces sibility Controls

Patents

US9487818: Top2A inhibition by temozolomide and its predictive value of GBM patient's survival

You are leaving this website